A Risk Based Approach to Quality

by | Dec 18, 2019 | FDA, Medical Devices, Quality Systems, Risk Management

ISO 13485:2016 emphasizes a risk-based approach to the entire QMS, shifting from the traditional risk approach which is highly product design-focused. ISO 14971-Risk Management for Medical Devices is the gold standard when it comes to applying a risk-based approach to the design and manufacturing of the medical device. But how do we ensure the application of a risk-based approach in Quality System Processes?

Assessing risk as part of supplier management usually starts with your approved suppliers’ list. Each supplier is categorized based on the risk it poses to the product and in turn the patient. Suppliers are not just raw materials manufacturers or providers of the various parts and components you purchase, but also consultants and contractors whose wrong judgment can affect product quality. So how do you mitigate this risk, read our blog Why Supplier Management is important for your medical device.

Risk management as part of nonconformance management assesses the manufacturing risks. The nonconformance disposition should be a risk-based decision. The aim should be to connect the nonconformance detected to the manufacturing and design risks identified.

Risk assessment as part of your complaint handling system should prompt you to evaluate the complaint and determine whether the severity and the probability of occurrence of the complaint cause were captured in the risk file. The received complaint might be a newly identified risk and an update may be required to the risk file. This is what keeps risk management active throughout the lifecycle of the product.

Last but not least, CAPAs address most of the issues that occur in the quality system. If the outcome of a CAPA is design or manufacturing related, then a review of the risk file should be done and if required, an update should be made.

The aim of this risk-based approach is to be proactive and detect any cause that can affect product safety and performance. With EMMA International’s proprietary methodology ‘CLIC’, you can achieve a holistic approach to your risk management program.

Reach out to us at info@emmainternational.com or at 248-987-4497 to know more.

Katie McCallum

Katie McCallum

More Resources

The 10 Golden Rules for GMP Production – Part 1

The 10 Golden Rules for GMP Production – Part 1

Good Manufacturing Practices (GMP) is a system that consists of processes, procedures and documentation that ensures products are consistently produced and controlled according to set quality standards; for pharmaceutical production this is especially important. In general, there are 10 golden rules that apply in order to fulfill the GMP requirements. This article is part 1 of a 2-part series that discusses the first 5 rules and why they are important.
The eSTAR 510k

The eSTAR 510k

The voluntary eSTAR (electronic Submission Template And Resource) is a fillable portable document format (PDF) document that seeks to make 510(k) and De Novo submissions quicker and easier due to its automation from its form construction and autofill capability
Medical Device Reporting

Medical Device Reporting

Medical device reporting (MDR) is one of the post market surveillance tools used by the FDA to monitor medical devices’ performance post release (21 CFR part 803)

Ready to learn more about working with us?

Pin It on Pinterest

Share This